Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
24.09
-0.40 (-1.63%)
Nov 21, 2024, 2:39 PM EST - Market open
Beam Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Beam Therapeutics stock have an average target of 45.9, with a low estimate of 24 and a high estimate of 80. The average target predicts an increase of 90.54% from the current stock price of 24.09.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BEAM stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 2 | 1 | 2 | 2 | 2 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 5 | 5 | 4 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 11 | 9 | 11 | 11 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +232.09% | Nov 7, 2024 |
RBC Capital | RBC Capital | Hold Maintains $27 → $24 | Hold | Maintains | $27 → $24 | -0.37% | Nov 6, 2024 |
Leerink Partners | Leerink Partners | Hold → Buy Upgrades $27 → $39 | Hold → Buy | Upgrades | $27 → $39 | +61.89% | Nov 6, 2024 |
Scotiabank | Scotiabank | Hold Initiates $24 | Hold | Initiates | $24 | -0.37% | Oct 16, 2024 |
RBC Capital | RBC Capital | Hold Reiterates $27 | Hold | Reiterates | $27 | +12.08% | Sep 19, 2024 |
Financial Forecast
Revenue This Year
51.21M
from 377.71M
Decreased by -86.44%
Revenue Next Year
54.30M
from 51.21M
Increased by 6.04%
EPS This Year
-4.82
from -1.72
EPS Next Year
-4.85
from -4.82
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 78.8M | 115.5M | 168.0M | ||
Avg | 51.2M | 54.3M | 57.3M | ||
Low | 28.6M | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -79.2% | 125.6% | 209.4% | ||
Avg | -86.4% | 6.0% | 5.5% | ||
Low | -92.4% | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -4.58 | -3.65 | -2.90 | ||
Avg | -4.82 | -4.85 | -4.44 | ||
Low | -4.93 | -5.33 | -5.48 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.